quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:01:45·108d
INSIDERFiling
Intensity Therapeutics Inc. logo

Chief Financial Officer Talamo Joseph was granted 14,482 shares, increasing direct ownership by 102% to 28,661 units (SEC Form 4)

INTS· Intensity Therapeutics Inc.
Health Care
Original source

Companies

  • INTS
    Intensity Therapeutics Inc.
    Health Care

Related

  • PR8d
    Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation
  • INSIDER24d
    SEC Form 4 filed by Bender Lewis H
  • SEC27d
    Intensity Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR27d
    Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update
  • SEC27d
    SEC Form 10-K filed by Intensity Therapeutics Inc.
  • PR30d
    Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US
  • SEC31d
    Intensity Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC31d
    SEC Form 424B5 filed by Intensity Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022